DGAP-News: Mainz Biomed Reports First Half 2022 Financial Re

07.09.2022 - Issuer: Mainz BioMed N.V. / Key word(s): Half Year Results Mainz Biomed Reports First Half 2022 Financial Results 07.09.2022 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. ●   127% year-over-year increase ...

Related Keywords

United Arab Emirates , Germany , Italy , Berkeley , California , United States , Americans , American , German , Rainer Metzger , Michele Pedrocchi , Mainz Biomed , Jane Edwards , Darin Leigh , Guido Baechler , National Cancer Institute , Key Corporate Product Development , Head Of Roche Diagnostics Business Development , Distribution Services , Centers For Medicare , Inherent To Dante Lab , End Results Program , European Union , News Service , Medicaid Services , American Cancer Society , Clinical Affairs , German Federal Ministry Of Education , Us Department Of Health , Human Services , Drug Administration , Children Health Insurance Program , Exchange Commission , Us Food Drug Administration , Business Development , Appointed Darin Leigh , Chief Commercial Officer , Dante Labs , Expanded Strategic Advisory Board , Chief Executive Officer , Vitro Diagnostic , North Rhine Westphalia , Dante Lab , Alert Rd Update , Approval Update , Health Insurance Program , Polymerase Chain Reaction , German Federal Ministry , Strategic Advisory Board , Abbott Diagnostics , Steve Quinn , Vice President , Roche Diagnostics Business Development , Cancer Statistics , Mortality Worldwide , Cancer Stat Facts , Pancreatic Cancer , Global Trends , Consolidated Statements , Six Months Ended June , United Arab , Real Time Polymerase Chain , Private Securities Litigation Reform Act , Corporate News , Regulatory Announcements , Dgap News ,